CSR writing
-
Avoiding Type I Error Misinterpretation in Clinical Study Reports: A Practical Perspective from Medical Writing By Femi Fajimi | 15 April 2026 (Educational content. No confidential information included.) In clinical trials, control of Type I error is a statistical responsibility defined in the protocol and the Statistical Analysis Plan (SAP). However, the interpretation and communication…
-
Clinical Trial Protocols and Clinical Study Reports (CSRs): A Beginner’s Perspective By Femi Fajimi | 28 April 2025 As I continue developing my skills in regulatory medical writing, I am learning how essential two key documents are to the clinical trial lifecycle: the protocol and the clinical study report (CSR). Protocols define a study’s blueprint,…
'Femi Fajimi 